Home | Publications | Diagnostics place holder
place holder place holder

Diagnostics

Women's Health: Diagnostic Testing


Publication Date   August 2008
Publisher   TriMark Publications
Product Type   Report
Pages   189
ISBN Number   not applicable
Product Code   TRI084
Ask a question about this product?

Price £1,225.00

approximately: $1,819 | €1,442

Summary


The purpose of this TriMark Publications report is to describe the specific segment of the in vitro diagnostics (IVDs) market called women's health testing. This study includes contemporary and generally accepted clinical and analytical activities. This analysis examines clinical measurement devices, as well as their reagents and supplies, as utilized in hospitals, clinics and doctor's offices. Some diagnostic tests, which are marketed primarily as over-the-counter products, are included in this report. This report also includes other important tests like mammography, (i.e., tests which are not generally associated with IVD tests, but which are an important component of the overall women's health market). This study deals with analysis related to the common chemical constituents of blood, plasma or serum of concern to patient testing in the field of women's health. Emphasis is on those companies and products that are actively developing and marketing clinical laboratory instrumentation, reagents and supplies for performing diagnostic tests related to women's health. This study concentrates on the women's health testing market segment in important worldwide markets such as the U.S., Japan and Europe.

Content


  • 1 Report Overview
    • 1.1 Objectives Of Report
    • 1.2 Scope Of Report
    • 1.3 Methodology
    • 1.4 Executive Summary
  • 2 Animal Health Products Antibacterial Markets
    • 2.1 Overview Of Animal Health Products Market
      • 2.1.1 World Products Market
      • 2.1.2 U.S. Animal Health Products Market
      • 2.1.3 European Animal Health Products Markets
      • 2.1.4 Asian Animal Health Products Markets
    • 2.2 Key Sector Highlights
    • 2.3 Biologics Products Category
    • 2.4 Companion Animal Health Products
  • 3 Common Animal Diseases
    • 3.1 Swine Fevers (African, Classical - Hog Cholera)
    • 3.2 Yellow Fever
    • 3.3 Anthrax
    • 3.4 Crimean-Congo Hemorrhagic Fever
    • 3.5 Foot And Mouth Disease (Fmd)
    • 3.6 Bovine Anaplasmosis
    • 3.7 Bovine Babesiosis
    • 3.8 Bovine Brucellosis
    • 3.9 Bovine Genital Campylobacteriosis
    • 3.10 Bovine Tuberculosis
    • 3.11 Bovine Cysticercosis
    • 3.12 Bovine Spongiform Encephalopathy
    • 3.13 Dermatophilosis
    • 3.14 Enzootic Bovine Leukosis
    • 3.15 Hemorrhagic Septicemia
    • 3.16 Infectious Bovine Rhinotracheitis / Infectious Pustular Vulvovaginitis
    • 3.17 Theileriosis
    • 3.18 Trichomonosis
    • 3.19 Vesicular Stomatitis
    • 3.20 Swine Vesicular Disease ? Picornaviridae Enterovirus
    • 3.21 Rinderpest
    • 3.22 Peste Des Petits Ruminants
    • 3.23 Contagious Bovine Pleuropneumonia
    • 3.24 Lumpy Skin Disease
    • 3.25 Rift Valley Fever
    • 3.26 Bluetongue ? Reoviridae Orbivirus
    • 3.27 Ovine Epididymitis (Brucella Ovis)
    • 3.28 Caprine And Ovine Brucellosis (Excluding B. Ovis)
    • 3.29 Caprine Arthritis/Encephalitis
    • 3.30 Contagious Agalactia
    • 3.31 Contagious Caprine Pleuropneumonia
    • 3.32 Enzootic Abortion Of Ewes (Ovine Chlamydiosis)
    • 3.33 Avian Chlamydiosis
    • 3.34 Pullorum Disease
    • 3.35 Myxomatosis
    • 3.36 Tularemia
    • 3.37 Contagious Equine Metritis
    • 3.38 Dourine
    • 3.39 Epizootic Lymphangitis
    • 3.40 Porcine Brucellosis
    • 3.41 Commercially-Significant Bacterial Infections In Farm Animals
  • 4 Anti-Bacterials Markets
    • 4.1 Overview
    • 4.2 Antibiotics Market Size
    • 4.3 Global Sales Of Animal Health Antibiotics By Region
      • 4.3.1 U.S. Sales Of Animal Health Antibiotics
      • 4.3.2 European Sales Of Animal Health Antibiotics
      • 4.3.3 Japanese Sales Of Animal Health Antibiotics
    • 4.4 Animal Health Antibiotics Market Drivers
    • 4.5 Growth Promotion In Livestock
  • 5 Regulatory Overview Of The Veterinary Health Market
    • 5.1 Regulatory Environment
    • 5.2 General Overview
    • 5.3 Product Marketing Authority
    • 5.4 Regulation Of Animal Health Products In The European Union
    • 5.5 Regulation Of Animal Health Products In The U.S
      • 5.5.1 Usda
      • 5.5.2 Fda
      • 5.5.3 Epa
    • 5.6 Regulation Of Animal Health Products In Japan
      • 5.6.1 Japanese Regulatory Environment
      • 5.6.2 Withdrawal Periods
      • 5.6.3 Japanese Filing Procedures For New Animal Drug Applications
      • 5.6.4 Use Of Outdated Animal Studies
      • 5.6.5 Brand-Specific Listing For Antimicrobial, Antibiotic And Other Feed Additives
    • 5.7 Proposed Regulation Of Animal Antibiotics
    • 5.8 Antibiotic Acquired Resistance And Animal Usage
  • 6 Business Trends In The Industry
    • 6.1 European Animal Health Industry
    • 6.2 Trends Driving Demand
    • 6.3 Antibiotic Usage
    • 6.4 Mergers And Acquisitions
    • 6.5 Bioterrorism And Food-Borne Pathogens?Who Guidelines
    • 6.6 Animal Health Additive Growth Trends
  • 7 Company Profiles
    • 7.1 Abbott Laboratories
    • 7.2 Agricultural Research Service
    • 7.3 Alpharma, Inc
    • 7.4 Basf Agricultural Products And Nutrition
    • 7.5 Bayer Animal Health
    • 7.6 Boehringer Ingelheim Corp
    • 7.7 Elanco Animal Health
    • 7.8 Fort Dodge Animal Health (Wyeth)
    • 7.9 Heska Animal Health
    • 7.10 Intervet International
    • 7.11 Ivax Corporation
    • 7.12 Merial Animal Health
    • 7.13 Novartis Animal Health
    • 7.14 Pfizer Animal Health
    • 7.15 Roche Animal Nutrition And Health
    • 7.16 Sanofi-Aventis
    • 7.17 Schering-Plough Animal Health
    • 7.18 Virbac S.A
    • 7.19 Wyeth (Fort Dodge Animal Health)
  • Index Of Figures
    • Figure 2.1: Worldwide Animal Health Products Market By Region, 2006
    • Figure 2.2: U.S. Companion Animal Healthcare Products Share Of Overall Animal Health Product Sales, 2006
    • Figure 2.3: Worldwide Animal Health Products Market By Species, 2006
  • Index Of Tables
    • Table 2.1: World Market For Animal Health Products, 2004-2012
    • Table 2.2: Global Sales Of Animal Health And Nutrition Products, 2004-2012
    • Table 2.3: Worldwide Animal Health Products Market By Region, 2006
    • Table 2.4: U.S. Animal Health Product Sales, 2004-2012
    • Table 2.5: Japanese Animal Health Market, 2000-2012
    • Table 2.6: Worldwide Animal Health Product Sales For Leading Producers, 2006
    • Table 2.7: Dog And Cat Food Manufacturers
    • Table 3.1: Diseases
    • Table 3.2: Multiple Species Diseases
    • Table 3.3: Cattle Diseases
    • Table 3.4: Sheep And Goat Diseases
    • Table 3.5: Equine Diseases
    • Table 3.6: Swine Diseases
    • Table 3.7: Avian Diseases
    • Table 3.8: Fish Diseases
    • Table 3.9: Other Veterinary Diseases
    • Table 3.10: Use Categories For Anti-Bacterials In Animal Health
    • Table 3.11: Commercially-Significant Bacterial Infections In Pigs
    • Table 3.12: Commercially-Significant Bacterial Infections In Poultry
    • Table 3.13: Commercially-Significant Bacterial Infections In Cattle
    • Table 4.1: Leading Antimicrobials By Type For Animal Health
    • Table 4.2: Antibiotics Used In Animal Health By Family
    • Table 4.3: Worldwide Sales Of Animal Health Antibiotics, 2004-2012
    • Table 4.4: U.S. Sales Of Animal Health Antibiotics, 2004-2012
    • Table 4.5: U.S. Volume Of Animal Health Antibiotics Used, 1999-2006
    • Table 4.6: Sales Of Bayer's Baytril, 2003-2009
    • Table 4.7: Enrofloxacin (Quinolones)
    • Table 4.8: Antibiotic Susceptibility For Common Swine Pathogens Vs. Excenel
    • Table 4.9: U.S. Volume Of Animal Health Antibiotics Used By Class Category, 2000-2005
    • Table 4.10: European Sales Of Animal Health Antibiotics, 2004-2012
    • Table 4.11: European Veterinary Consumption Of Therapeutic Antibiotics
    • Table 4.12: Japanese Sales Of Animal Health Antibiotics, 2004-2012
    • Table 4.13: Animal Health Antibiotics Market Drivers
    • Table 4.14: Commercial Animal Health Anti-Bacterials By Class Type
    • Table 4.15: Bacterial And Protozoal Threats To Poultry
    • Table 4.16: Bacterial And Protozoal Threats To Pigs
    • Table 7.1: Pfizer Animal Health Products
    • Table 7.2: Pfizer Livestock Products
    • Table 7.3: Pfizer Equine Products
    • Table 7.4: Pfizer Companion Animal Products